The use of various social media platforms for dissemination of orphan disease research information has created a cornucopia of possibilities enabling clinical trial performance. Read this white paper to learn about social media opportunities in rare disease drug development.
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
